Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals

Simple Summary Colorectal and endometrial cancers are the most important life-threating risk in Lynch syndrome subjects, with incidences at 75 years as high as 40–60%. However, surveillance has shown to be ineffective. Risk reducing surgeries are an option in Lynch Syndrome (LS) individuals to decrease incidence of this type of cancers. In this manuscript, we have analyzed the rates of colorectal and gynecological cancer in 976 LS individuals after a mean follow-up of 10.2 years (patients under regular surveillance or after a risk reducing surgery). We can confirm in the largest study published up to the present in a single-institution that risk reducing surgeries are effective in decreasing incidence of colorectal and gynecological cancer in all LS carriers. Moreover, is the first report showing a decrease in all-cause mortality cumulative incidence in females with Lynch syndrome that undergo gynecological risk reducing surgery. Abstract Background: Colorectal (CRC) and endometrial cancer (EC) are the most common types of cancer in Lynch syndrome (LS). Risk reducing surgeries (RRS) might impact cancer incidence and mortality. Our objectives were to evaluate cumulative incidences of CRC, gynecological cancer and all-cause mortality after RRS in LS individuals. Methods: Retrospective analysis of 976 LS carriers from a single-institution registry. Primary endpoints were cumulative incidence at 75 years of cancer (metachronous CRC in 425 individuals; EC and ovarian cancer (OC) in 531 individuals) and all-cause mortality cumulative incidence, comparing extended (ES) vs. segmental surgery (SS) in the CRC cohort and risk reducing gynecological surgery (RRGS) vs. surveillance in the gynecological cohort. Results: Cumulative incidence at 75 years of metachronous CRC was 12.5% vs. 44.7% (p = 0.04) and all-cause mortality cumulative incidence was 38.6% vs. 55.3% (p = 0.31), for ES and SS, respectively. Cumulative, incidence at 75 years was 11.2% vs. 46.3% for EC (p = 0.001) and 0% vs. 12.7% for OC (p N/A) and all-cause mortality cumulative incidence was 0% vs. 52.7% (p N/A), for RRGS vs. surveillance, respectively. Conclusions: RRS in LS reduces the incidence of metachronous CRC and gynecological neoplasms, also indicating a reduction in all-cause mortality cumulative incidence in females undergoing RRGS.

[1]  M. Kloor,et al.  European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender , 2021, The British journal of surgery.

[2]  Aung Ko Win,et al.  Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database , 2020, Genetics in Medicine.

[3]  B. Bonanni,et al.  Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database , 2020, Journal of clinical medicine.

[4]  D. Bishop,et al.  Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial , 2020, The Lancet.

[5]  G. Spolverato,et al.  Analysis of morbidity and mortality, quality of life and bowel function after total colectomy with ileorectal anastomosis versus right and left hemicolectomy: A study to optimise the treatment of lynch syndrome and attenuated polyposis coli. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  J. Oh,et al.  Analysis of metachronous colorectal neoplasms and survival following segmental or extended resection in patients with hereditary non-polyposis colorectal cancer , 2020, International Journal of Colorectal Disease.

[7]  M. Kloor,et al.  Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome. , 2020, Gastroenterology.

[8]  I. Tomlinson,et al.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) , 2019, Gut.

[9]  M. Kloor,et al.  Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report , 2019, Hereditary Cancer in Clinical Practice.

[10]  E. Martinelli,et al.  Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  Aung Ko Win,et al.  Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database , 2019, Genetics in Medicine.

[12]  P. Møller,et al.  The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome , 2019, Genetics in Medicine.

[13]  M. Kloor,et al.  Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report , 2019, Hereditary Cancer in Clinical Practice.

[14]  M. Kloor,et al.  No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies. , 2018, Gastroenterology.

[15]  Aung Ko Win,et al.  Cancer Risks for PMS2-Associated Lynch Syndrome. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Kloor,et al.  Three molecular pathways model colorectal carcinogenesis in Lynch syndrome , 2018, International journal of cancer.

[17]  H. Lynch,et al.  Efficacy of proximal colectomy for surgical management of right-sided first colorectal cancer in Lynch Syndrome mutation carriers. , 2018, American journal of surgery.

[18]  P. Møller,et al.  Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report , 2017, Hereditary cancer in clinical practice.

[19]  J. Mecklin,et al.  Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome , 2017, Diseases of the colon and rectum.

[20]  O. Faiz,et al.  Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta‐analysis , 2017, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[21]  P. Møller,et al.  Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database , 2016, Gut.

[22]  D. Chang,et al.  Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome , 2017, Annals of Surgical Oncology.

[23]  M. Kloor,et al.  CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome , 2016, Familial Cancer.

[24]  M. Hurley.  A reference relative time-scale as an alternative to chronological age for cohorts with long follow-up , 2015, Emerging Themes in Epidemiology.

[25]  P. Møller,et al.  Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database , 2015, Gut.

[26]  Z. Cohen,et al.  DNA Mismatch Repair Status Predicts Need for Future Colorectal Surgery for Metachronous Neoplasms in Young Individuals Undergoing Colorectal Cancer Resection , 2015, Diseases of the colon and rectum.

[27]  H. Heneghan,et al.  Segmental vs extended colectomy in the management of hereditary nonpolyposis colorectal cancer: a systematic review and meta‐analysis , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[28]  E. Dicks,et al.  Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers , 2015, Hereditary cancer in clinical practice.

[29]  Randall W Burt,et al.  ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.

[30]  A. Wagner,et al.  Guidelines on genetic evaluation and management of Lynch syndrome. , 2015, Gastrointestinal endoscopy.

[31]  R. Moldovan,et al.  The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome , 2015, Familial Cancer.

[32]  Randall W Burt,et al.  Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. , 2014, Diseases of the colon and rectum.

[33]  Rodney J Scott,et al.  Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.

[34]  H. Hollema,et al.  The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome. , 2013, Gynecologic oncology.

[35]  F. Ghezzi,et al.  Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature. , 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[36]  J. Potter,et al.  Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.

[37]  E. Dekker,et al.  Quality of Life After Surgery for Colon Cancer in Patients With Lynch Syndrome: Partial Versus Subtotal Colectomy , 2012, Diseases of the colon and rectum.

[38]  R. Ramesar,et al.  Surgery for colonic cancer in HNPCC: total vs segmental colectomy , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[39]  P. V. van Diest,et al.  Pathology of hereditary breast cancer , 2011, Cellular oncology.

[40]  P. Diest,et al.  Pathology of hereditary breast cancer , 2011, Cellular Oncology.

[41]  Aung Ko Win,et al.  Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery , 2010, Gut.

[42]  J. Church,et al.  Risk of Colorectal Adenoma and Carcinoma After Colectomy for Colorectal Cancer in Patients Meeting Amsterdam Criteria , 2010, Annals of surgery.

[43]  C. Boland,et al.  Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. , 2010, Gastroenterology.

[44]  E. Dekker,et al.  One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. , 2010, Gastroenterology.

[45]  H. Lynch,et al.  Comparison of Extended Colectomy and Limited Resection in Patients With Lynch Syndrome , 2010, Diseases of the colon and rectum.

[46]  M. Munsell,et al.  Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. , 2006, The New England journal of medicine.

[47]  J. Kleibeuker,et al.  Surveillance for Hereditary Nonpolyposis Colorectal Cancer , 2002 .

[48]  J. Kleibeuker,et al.  Surveillance for Hereditary Nonpolyposis Colorectal Cancer , 2002 .

[49]  L. Aaltonen,et al.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.

[50]  J. Jass,et al.  Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. , 1997, Annals of surgery.

[51]  E L Korn,et al.  Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. , 1997, American journal of epidemiology.

[52]  J. Mecklin,et al.  Surveillance in hereditary nonpolyposis colorectal cancer: An international cooperative study of 165 families , 1993, Diseases of the colon and rectum.